| Identification | Back Directory | [Name]
RGDV | [CAS]
93674-99-8 | [Synonyms]
RGDV ARG-GLY-ASP-VAL H-ARG-GLY-ASP-VAL-OH arginyl-glycyl-aspartyl-valine | [Molecular Formula]
C17H31N7O7 | [MDL Number]
MFCD00076456 | [MOL File]
93674-99-8.mol | [Molecular Weight]
445.47 |
| Hazard Information | Back Directory | [Uses]
RGDV is a platelet aggregation inhibitor. RGDV inhibits platelet-dependent thrombus formation. RGDV is used for tumor recognition via the targeting effect[1][2]. | [References]
[1] Cadroy Y, et, al. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model. J Clin Invest. 1989 Sep;84(3):939-44. DOI:10.1172/JCI114256 [2] Wang F, et, al. Preparation and biological evaluation of tumor-specific Ara-C liposomal preparations containing RGDV motif. J Pharm Sci. 2012 Dec;101(12):4559-68. DOI:10.1002/jps.23326 |
|
|